1. Home
  2. LMFA vs INAB Comparison

LMFA vs INAB Comparison

Compare LMFA & INAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LM Funding America Inc.

LMFA

LM Funding America Inc.

HOLD

Current Price

$0.84

Market Cap

10.6M

Sector

Finance

ML Signal

HOLD

Logo IN8bio Inc.

INAB

IN8bio Inc.

HOLD

Current Price

$1.72

Market Cap

10.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMFA
INAB
Founded
2008
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.6M
10.6M
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
LMFA
INAB
Price
$0.84
$1.72
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$5.00
$108.00
AVG Volume (30 Days)
639.3K
49.4K
Earning Date
11-14-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,567,508.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$17.20
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.75
$1.53
52 Week High
$5.14
$12.53

Technical Indicators

Market Signals
Indicator
LMFA
INAB
Relative Strength Index (RSI) 41.45 44.40
Support Level $0.87 $1.73
Resistance Level $0.97 $1.80
Average True Range (ATR) 0.06 0.13
MACD 0.00 0.00
Stochastic Oscillator 36.88 29.16

Price Performance

Historical Comparison
LMFA
INAB

About LMFA LM Funding America Inc.

LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

Share on Social Networks: